Budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler, formulated using co-suspension delivery technology, improves lung function and exacerbation outcomes in patients with COPD without a recent history of exacerbations: subgroup analysis of KRONOS study
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2019 ◽
Vol Volume 14
◽
pp. 2979-2991
◽
2020 ◽
Keyword(s):
2020 ◽
Vol 153
◽
pp. 105472
Keyword(s):
2018 ◽
Vol Volume 13
◽
pp. 2673-2684
◽
Keyword(s):
2021 ◽
Vol Volume 16
◽
pp. 179-189
Keyword(s):